Breast (Apr 2021)

(Trial in progress) A real-life prospective, observational, post-authorisation safety study in adult breast cancer patients treated with neratinib in extended adjuvant in Europe: the NERLYFE study

  • R. Valenti,
  • C. Plantet,
  • A. Tadmouri

Journal volume & issue
Vol. 56
p. S20

Abstract

Read online

No abstracts available.